TABLE 2.
Demographic and clinical data at the time of stool collection
| Variables | At the time stool collection | P | ||
|---|---|---|---|---|
| All patients | No Recurrent | Recurrent | ||
| NAFLD | NAFLD | |||
| N = 21 | N = 6 | N = 15 | ||
| Age | 63 ± 7 | 62 ± 8 | 63 ± 8 | 0.82 |
| Male gender | 11 (53) | 4 (67) | 7 (47) | 0.64 |
| Race (White) | 21 (100) | 6 (100) | 15 (100) | 1 |
| Diabetes | 13 (62) | 3 (50) | 10 (67) | 0.63 |
| BMI (kg/m2) | 33 ± 8 | 38 ± 11 | 31 ± 6 | 0.15 |
| AST (IU/mL) | 38 ± 21 | 22 ± 7 | 44 ± 21 | 0.01 |
| ALT (IU/mL) | 51 ± 32 | 32 ± 10 | 58 ± 35 | 0.04 |
| T. Bili (mg/dL) | 0.7 ± 0.4 | 1 ± 0.6 | 0.6 ± 0.4 | 0.15 |
| ALP (IU/mL) | 95 ± 42 | 74 ± 42 | 103 ± 40 | 0.29 |
| Albumin (g/dL) | 4 ± 0.4 | 4 ± 0.32 | 4.14 ± 0.45 | 0.56 |
| Cr (mg/dL) | 1.2 ± 0.4 | 1 ± 0.2 | 1.17 ± 0.47 | 0.64 |
| Hgb (g/dL) | 13.4 ± 2.1 | 14.5 ± 0.9 | 13 ± 2.3 | 0.18 |
| WBC (x103/uL) | 5.8 ± 2.6 | 6.7 ± 1.9 | 5.5 ± 2.8 | 0.16 |
| INR | 1.04 ± 0.1 | 0.97 ± 0.1 | 1.05 ± 0.1 | 0.15 |
| Triglycerides (mg/dL) | 213 ± 109 | 120 ± 43 | 246 ± 107 | 0.02 |
| Cholesterol (mg/dL) | 164 ± 38 | 155 ± 19 | 167 ± 43 | 0.62 |
| HDL (mg/dL) | 38 ± 8 | 41 ± 8 | 37 ± 8 | 0.26 |
| LDL (mg/dL) | 91 ± 39 | 93 ± 19 | 90 ± 44 | 0.89 |
| HbA1c (%) | 6.4 ± 1.1 | 6.0 ± 1.3 | 6.5 ± 1.0 | 0.38 |
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; Cr, creatinine; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; Hgb, hemoglobin; INR, international normalized ratio; LDL, low-density lipoprotein; NAFLD, nonalcoholic fatty liver disease; T. Bili, total bilirubin; WBC, white blood cell count.